NEW
YORK, March 17, 2023 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Caribou Biosciences, Inc.
(NASDAQ: CRBU).
To receive updates on the lawsuit, fill out the
form:
https://claimyourloss.com/securities/caribou-biosciences-inc-loss-submission-form/?id=37358&from=4
This lawsuit is on behalf of persons and entities that purchased
or otherwise acquired: (a) Caribou common stock pursuant and/or
traceable to documents issued in connection with the Company's
initial public offering conducted on or about July 23, 2021; and/or (b) Caribou securities
between July 23, 2021, and
December 9, 2022.
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
April 11, 2023 to petition the
court. Your ability to share in any recovery doesn't require that
you serve as a lead plaintiff.
According to a filed complaint, Caribou Biosciences, Inc. issued
materially false and/or misleading statements and/or failed to
disclose that: (i) the treatment effect of the Company's
product candidate, CB-010, was not as durable as defendants had led
investors to believe; (ii) accordingly, CB-010's clinical and
commercial prospects were overstated; and (iii) as a result,
documents issued in connection with Caribou's initial public offer
and defendants' public statements throughout the class period were
materially false and/or misleading and failed to state information
required to be stated therein.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/crbu-shareholder-alert-jakubowitz-law-reminds-caribou-shareholders-of-a-lead-plaintiff-deadline-of-april-11-2023-301774663.html
SOURCE Jakubowitz Law